Gilead Sciences, Inc. (NASDAQ:GILD) increased 0.65% to close at $38.98. GILD traded 7.77 million shares for the day and its earning per share remained $3.42. Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics. The Company has operations in North America, Europe and Australia. The Company sells and distributes Truvada, Viread, Emtriva, Hepsera and AmBisome in Asia, Australia, Europe, Latin America, the Middle East and New Zealand, through its commercial teams, third party distributors or partners.
NuVasive, Inc. (NASDAQ:NUVA) increased 1.57% to close at $25.20. NUVA traded 1.20 million shares for the day and its earning per share remained $0.46. NuVasive, Inc. (NuVasive) is a medical device company. It focuses on the designing, developing and marketing of products for the surgical treatment of spine disorders. Its product portfolio is focused on applications for spine fusion surgery. Its principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery (NYSE:MAS), as well as offering of biologics, cervical and motion preservation products.
Patterson Companies, Inc. (NASDAQ:PDCO) increased 1.37% to close at $28.91. PDCO traded 1.02 million shares for the day and its earning per share remained $1.85. Patterson Companies, Inc. (Patterson) is a distributor serving three markets: North American dental supply, U.S. companion-pet (dogs, cats and other common household pets) and equine veterinary supply, and the global rehabilitation and assistive products supply market. The Company operates in three segments: dental supply, veterinary supply and rehabilitation supply.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.
Disclosure: No positions